Call for sponsors & exhibitors
Venoms 2018 invites commercial sponsorship for demonstration of R&D and laboratory supplies related to field and laboratory venom research. We offer a number of highly competitive packages (examples below). If your needs are not covered by the offered packages please contact us in the first instance and we shall do our best to develop a package to suit your requirements.
Sponsorship packages
- Gold: Includes a speaker slot AND an exhibition stand, plus four free passes (max 3)
- Silver: Includes a speaker slot OR an exhibition stand, plus three free passes (max 3)
- Bronze: Includes exhibition stand, plus two free passes (Max 3)
- Drinks Reception
- Delegate Bags (max 2)
- Delegate Badges (max 2)
- Event Documentation (max 2)
- Exhibition stand
For Booking Form, terms and conditions, and further information about packages and other promotional opportunities email at:
Venoms 2018 Sponsors
Media Sponsor
Website: http://jvenomres.co.uk
LinkedIn: https://www.linkedin.com/groups/3553905
Twitter: @VenomsOxford; hashtag #JVenRes
Publish free until 15 December 2017:
We are happy to waive the basic open access fee for manuscript submitted until 15 December 2017, as long as the manuscripts are prepared according to the published guidelines.
The Journal (ISSN: 2044-0324) will publish high-quality peer-reviewed articles addressing most aspects of therapeutic, molecular, biochemical and evolutionary research on venoms, and envenomation. The Journal aims at providing an efficient route to fast-track publication, within 10-12 weeks of manuscript submission if accepted. Furthermore, manuscripts will be made available online in their final form generally within 2-3 weeks of final acceptance.
The Journal will be primarily published online but on sufficient demand for printed version journal hard copies may also be provided to individuals and institutions.
Manuscripts in the following categories will be considered for publication: reviews, mini-reviews, research articles, research reports, research letters, clinical reports, case studies, new methods and technologies, meeting reports and commercial, patent and product news and editorials.
The Journal is currently indexed in:
- PubMed Central
- UKPMC
- PMC Canada
- The Directory of Open Access Journals
- Google Scholar
- OPEN J-Gate
- Chemical Abstracts Service (CAS)
- Academic Search Complete (EBSCO)
For further information, please visit http://jvenomres.co.uk or email at jvr.submit@gmail.com.
